Ipilimumab Induced Encephalitis: A Case Report

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

2015 • 1,997 citations

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

2009 • 1,139 citations

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

2007 • 673 citations

Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody

2014 • 607 citations

Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma

2014 • 277 citations

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

2013 • 198 citations

Drug-Associated Dermatomyositis Following Ipilimumab Therapy

2014 • 150 citations

Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

2011 • 123 citations

A Severe Case of Ipilimumab-Induced Guillain-Barré Syndrome Revealed by an Occlusive Enteric Neuropathy

2012 • 89 citations

Ipilimumab-Induced Encephalopathy with a Reversible Splenial Lesion

2015 • 61 citations

Peripheral Neuropathy Associated With Ipilimumab

2015 • 53 citations

Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature

2015 • 41 citations

Ipilimumab for advanced melanoma: A pharmacologic perspective

2012 • 17 citations